Shanghai Pharmaceutical Co., Ltd. Ups Stake in Shanghai Sunway Biotech Co. Ltd.
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
June 25, 2013 -- Shanghai Pharmaceuticals purchased another 11% of Shanghai Sunway Biotech, bringing its total holdings in the company to 81%. In 2005, Sunway was granted CFDA approval of a gene therapy treatment, using an oncolytic adenovirus as a delivery vehicle, for late-stage refractory nasopharyngeal cancer. Shanghai Pharma paid 1 million RMB ($160,000) for its purchase of the 11% stake. More details....
Stock Symbols: (SHA: 601607)
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
June 25, 2013 -- Shanghai Pharmaceuticals purchased another 11% of Shanghai Sunway Biotech, bringing its total holdings in the company to 81%. In 2005, Sunway was granted CFDA approval of a gene therapy treatment, using an oncolytic adenovirus as a delivery vehicle, for late-stage refractory nasopharyngeal cancer. Shanghai Pharma paid 1 million RMB ($160,000) for its purchase of the 11% stake. More details....
Stock Symbols: (SHA: 601607)
Help employers find you! Check out all the jobs and post your resume.